Literature DB >> 3372691

Enhanced neutrophil chemiluminescence in familial Mediterranean fever.

P A Anton1, S R Targan, S R Vigna, M Durham, A D Schwabe, F Shanahan.   

Abstract

Familial Mediterranean Fever is a disorder of unknown cause characterized by recurrent, self-limited paroxysms of serosal inflammation. Although the neutrophil is the predominant cell involved, no cellular abnormalities are known. Chemiluminescence was studied in neutrophils from 20 asymptomatic patients with this disease and 21 healthy controls to evaluate the oxidative response to formyl-methionyl-leucyl-phenylalanine (f-met-leu-phe). In a subset of patients with familial Mediterranean fever, neutrophils but not monocytes were shown to have significantly enhanced chemiluminescence compared to controls. The enhanced responsiveness of neutrophils to f-met-leu-phe in this disease was found to occur at a postreceptor level. Receptor binding assays demonstrated no differences in binding affinity and receptor number between patients and controls. In addition, a similar enhancement in chemiluminescence was observed with an alternative stimulus (zymosan). In contrast to chemiluminescence, chemotaxis induced by f-met-leu-phe was not enhanced in patients with familial Mediterranean fever. The enhanced neutrophil chemiluminescence may identify a subclinical inflammatory state in attack-free patients with familial Mediterranean fever, as enhanced chemiluminescence is also observed in chronic inflammatory diseases with active inflammation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3372691     DOI: 10.1007/bf00917903

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  27 in total

1.  Familial Mediterranean fever.

Authors:  H HELLER; E SOHAR; L SHERF
Journal:  AMA Arch Intern Med       Date:  1958-07

2.  Periodic peritonitis; heredity and pathology: report of seventy-two cases.

Authors:  H A REIMANN; J MOADIE; S SEMERDJIAN; P F SAHYOUN
Journal:  J Am Med Assoc       Date:  1954-04-10

3.  Effects of a chemotactic factor, N-formylmethionyl peptide, on adherence, superoxide anion generation, phagocytosis, and microtubule assembly of human polymorphonuclear leukocytes.

Authors:  L A Boxer; M Yoder; S Bonsib; M Schmidt; P Ho; R Jersild; R L Baehner
Journal:  J Lab Clin Med       Date:  1979-03

4.  Familial Mediterranean Fever in Armenians. Analysis of 100 cases.

Authors:  A D Schwabe; R S Peters
Journal:  Medicine (Baltimore)       Date:  1974-11       Impact factor: 1.889

5.  Diminished activity of a chemotactic inhibitor in synovial fluids from patients with familial Mediterranean fever.

Authors:  Y Matzner; R E Partridge; M Levy; B M Babior
Journal:  Blood       Date:  1984-03       Impact factor: 22.113

6.  C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever.

Authors:  Y Matzner; A Brzezinski
Journal:  N Engl J Med       Date:  1984-08-02       Impact factor: 91.245

7.  C5a-inhibitor deficiency--a role in familial Mediterranean fever?

Authors:  A D Schwabe; T J Lehman
Journal:  N Engl J Med       Date:  1984-08-02       Impact factor: 91.245

8.  Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever.

Authors:  C A Dinarello; M J Chusid; A S Fauci; J I Gallin; D C Dale; S M Wolff
Journal:  Arthritis Rheum       Date:  1976 May-Jun

Review 9.  Familial Mediterranean fever: report of a large family, review of the literature, and discussion of the frequency of amyloidosis.

Authors:  J Meyerhoff
Journal:  Medicine (Baltimore)       Date:  1980-01       Impact factor: 1.889

10.  Chemiluminescence of phagocytic cells caused by N-formylmethionyl peptides.

Authors:  G E Hatch; D E Gardner; D B Menzel
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  7 in total

1.  Recurrent hereditary polyserositis.

Authors:  G C Cook
Journal:  BMJ       Date:  1990-11-17

2.  Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever.

Authors:  Eren Erken; Huseyin T E Ozer; Ramazan Gunesacar
Journal:  Rheumatol Int       Date:  2006-01-06       Impact factor: 2.631

Review 3.  Chronic inflammation in FMF: markers, risk factors, outcomes and therapy.

Authors:  Ilan Ben-Zvi; Avi Livneh
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

4.  Increased luminol-enhanced chemiluminescence of blood monocytes and granulocytes in Hodgkin's disease.

Authors:  O Tullgren; R Giscombe; G Holm; B Johansson; H Mellstedt; M Björkholm
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

5.  Can serum fetuin-A be regarded as an inflammatory marker among patients with familial Mediterranean fever?

Authors:  Kemal Oncu; Yusuf Yazgan; Alpaslan Tanoglu; Mustafa Kaplan; Fatih Ermis; Osman Metin Ipcioglu; Muammer Kara; Irfan Kucuk; Halil Onur Ozari
Journal:  Dig Dis Sci       Date:  2013-08-08       Impact factor: 3.199

6.  Using urinary neutrophile gelatinase-associated lipocalin for prognosticate renal dysfunction in children with familial Mediterranean fever the study design: a pilot study.

Authors:  Sinem Can Oksay; Hasan Dursun; Sebnem Tekin Neijmann; Sami Hatipoglu
Journal:  Adv Rheumatol       Date:  2021-04-01

7.  Neutrophils from patients with SAPHO syndrome show no signs of aberrant NADPH oxidase-dependent production of intracellular reactive oxygen species.

Authors:  Per Wekell; Halla Björnsdottir; Lena Björkman; Martina Sundqvist; Karin Christenson; Veronica Osla; Stefan Berg; Anders Fasth; Amanda Welin; Johan Bylund; Anna Karlsson
Journal:  Rheumatology (Oxford)       Date:  2016-04-27       Impact factor: 7.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.